Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients
- 1 December 2024
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 85 (4) , 344-353
Abstract
Background: To investigate the utility of diffusion‐weighted magnetic resonance imaging (DW‐MRI) in evaluating Gleason score (GS) 7 tumors before definitive radiotherapy (RT) and to explore its association with clinicopathological factors and treatment outcomes.Materials and Methods: Clinical data of 266 prostate cancer (PCa) patients with biopsy‐confirmed GS 7 who underwent RT were retrospectively analyzed. Pretreatment DW‐MRI was utilized to measure apparent diffusion coefficient (ADC) values of primary tumors. Treatment outcomes, including biochemical disease‐free survival (bDFS) and prostate cancer‐specific survival (PCSS), were assessed. Statistical analyses were conducted to determine the correlation between tumor ADC values, clinicopathological factors, and treatment outcomes.Results: Tumors with a GS of 3 + 4 had significantly higher ADC values than those with a GS of 4 + 3 (0.746 ± 0.150 vs. 0.702 ± 0.157 × 10−³ mm²/s; p < 0.001). Median follow‐up time was 8.6 years, and the 7‐year rates for bDFS and PCSS were 89.1% and 95.3%, respectively. Lower tumor ADC values were significantly correlated with higher GS and increased risk of disease progression. A primary tumor ADC cutoff value of 0.682 × 10−³ mm²/s was identified for predicting disease progression. Patients with higher ADC values exhibited significantly better 7‐year bDFS rates (92.8% vs. 83.2%; p = 0.02). However, GS 4 + 3 tumors independently predicted poorer bDFS and PCSS outcomes. In the multivariable analysis, only GS 4 + 3 tumor was predictive for worse bDFS and PCSS.Conclusions: Tumor ADC values are a reliable biomarker for differentiating between GS 3 + 4 and 4 + 3 tumors in the GS 7 category. Tumors exhibiting lower ADC values have been associated to higher risk factors and an increased likelihood of disease progression, particularly in GS 3 + 4 tumors where GS upgrading could happen.Keywords
This publication has 32 references indexed in Scilit:
- Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patientsThe Prostate, 2023
- The highest percentage of Gleason Pattern 4 is a predictor in intermediate‐risk prostate cancerBJUI Compass, 2022
- Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 + 4 and 4 + 3 prostate cancerAbdominal Radiology, 2018
- The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancerStrahlentherapie und Onkologie, 2017
- Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapyJournal of Magnetic Resonance Imaging, 2016
- Whole‐lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomyJournal of Magnetic Resonance Imaging, 2014
- Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRIEuropean Radiology, 2012
- Diffusion‐weighted imaging of the abdomen at 3.0 Tesla: Image quality and apparent diffusion coefficient reproducibility compared with 1.5 TeslaJournal of Magnetic Resonance Imaging, 2010
- Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial resultsEuropean Radiology, 2010
- Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathologyJournal of Magnetic Resonance Imaging, 2007